KDR and neoplasm: For instance, disruption of α2,6-sialylation leads to the loss of PECAM-VEGFR2 complexes, increases VEGFR2 internalization and VEGFR-dependent signaling, and impairs tumor angiogenesis through enhanced endothelial apoptosis [23].